Contact
Please use this form to send email to PR contact of this press release:
Headway in Alzheimer’s Disease Care: New Guidance Provides Recommendations for Use of Anti-Amyloid Monoclonal Antibodies
TO:
Christine Hohlbaum
Hohlbaum PR & Social Media
+49 177 8638661